Authors:
OREILLY JF
WEIR DC
BANHAM S
BASRAN GS
BOYD G
PATEL KR
Citation: Jf. Oreilly et al., IS HIGH-DOSE FLUTICASONE PROPIONATE VIA A METERED-DOSE INHALER AND VOLUMATIC(TM) AS EFFICACIOUS AS NEBULIZED BUDESONIDE IN ADULT ASTHMATICS, Respiratory medicine, 92(1), 1998, pp. 111-117
Authors:
DEV D
HUGHES C
SMITH MJ
TILLOTSON G
BASRAN GS
Citation: D. Dev et al., HIGH-DOSE PARENTERAL CIPROFLOXACIN IN PLEURO-PULMONARY DISEASE - A COMPARATIVE PHARMACOKINETICS OF 400 AND 200 MG INTRAVENOUS, International journal of antimicrobial agents, 8(2), 1997, pp. 93-95
Authors:
GOONETILLEKE AKE
DEV D
AZIZ I
HUGHES C
SMITH MJ
BASRAN GS
Citation: Ake. Goonetilleke et al., A COMPARATIVE-ANALYSIS OF PHARMACOKINETICS OF CEFTRIAXONE IN SERUM AND PLEURAL FLUID IN HUMANS - A STUDY OF ONCE-DAILY ADMINISTRATION BY INTRAMUSCULAR AND INTRAVENOUS ROUTES, Journal of antimicrobial chemotherapy, 38(6), 1996, pp. 969-976
Citation: Gs. Basran et al., THE EFFICACY OF BUDESONIDE AND BECLOMETHASONE DIPROPIONATE, DELIVEREDVIA A PRESSURIZED METERED-DOSE INHALER, IN THE TREATMENT OF PERENNIALRHINITIS - A RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY, American journal of rhinology, 9(5), 1995, pp. 285-290
Authors:
GOONETILLEKE AKE
KRAUSE K
SLATER DN
DEV D
WOOD ML
BASRAN GS
Citation: Ake. Goonetilleke et al., PRIMARY CUTANEOUS CRYPTOCOCCOSIS IN AN IMMUNOCOMPROMIZED PIGEON KEEPER, British journal of dermatology, 133(4), 1995, pp. 650-652
Citation: J. Joseph et al., PENETRATION OF INTRAVENOUS AND ORAL CIPROFLOXACIN INTO STERILE AND EMPYEMIC HUMAN PLEURAL FLUID, The Annals of pharmacotherapy, 28(3), 1994, pp. 313-315
Citation: D. Dev et al., IMMUNODEFICIENCY WITHOUT HIV - CONSIDER HIV-NEGATIVE IMMUNODEFICIENCYIN CRYPTOCOCCOSIS, BMJ. British medical journal, 308(6941), 1994, pp. 1436-1436
Citation: Gs. Basran, INDO-CANADIAN FAMILIES HISTORICAL CONSTRAINTS AND CONTEMPORARY CONTRADICTIONS, Journal of comparative family studies, 24(3), 1993, pp. 339-352